CORDIS
EU research results

CORDIS

English EN

Scaling-up Packages of Interventions for Cardiovascular disease prevention in selected sites in Europe and Sub-Saharan Africa: An implementation research (SPICES Project)

Project information

Grant agreement ID: 733356

Status

Ongoing project

  • Start date

    1 January 2017

  • End date

    31 December 2021

Funded under:

H2020-EU.3.1.6.

  • Overall budget:

    € 5 902 038,75

  • EU contribution

    € 5 902 038,75

Coordinated by:

UNIVERSITEIT ANTWERPEN

Belgium

Objective

The overall research objective of the SPICES project is to implement and evaluate a comprehensive CVD prevention and control program in five settings: a rural & semi-urban community in a low-income country (Uganda), middle income (South Africa) and vulnerable groups in three high-income countries (Belgium, France and United Kingdom) as well as to identify and compare the barriers and facilitators across study contexts. The project will be evaluated using a mix of formative assessments; pre/post and trial designs. At the beginning of the project, we will conduct baseline assessments including literature reviews, formative studies, household surveys (where feasible) and learn lessons from other projects to understand healthcare and lifestyle practices, barriers, and facilitators. A cost-effectiveness and cost benefit analysis will be included. In addition, the teams will conduct site exchanges visits to learn from each other and organise policy dialogues to ensure sustainability and maximise impact of the interventions. The implementation outcomes—acceptability, adoption, appropriateness, feasibility, fidelity, implementation cost, coverage, and sustainability will be evaluated – in order to understand the factors affecting the implementation, the processes, and the accruing results. The intervention of the SPICES project will aim to: (1) improve patients ’risk profiles (LDL-cholesterol, blood pressure, HbA1c (among patients with diabetes), modify lifestyles (diet and exercise and smoking cessation) and achieve recommended cholesterol, blood pressure and glycaemic control targets; (2) increase proportion of patients receiving appropriate BP, cholesterol and diabetes medication; (3) and mitigate the number of people developing complications such a stroke and myocardial infarction.

Coordinator

UNIVERSITEIT ANTWERPEN

Address

Prinsstraat 13
2000 Antwerpen

Belgium

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 599 662,50

Participants (6)

MAKERERE UNIVERSITY

Uganda

EU Contribution

€ 901 837,50

CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE BREST

France

EU Contribution

€ 1 022 137,50

THE UNIVERSITY OF MANCHESTER

United Kingdom

EU Contribution

€ 61 950,10

THE NOTTINGHAM TRENT UNIVERSITY

United Kingdom

EU Contribution

€ 651 671,25

University of Limpopo

South Africa

EU Contribution

€ 788 125

THE UNIVERSITY OF SUSSEX

United Kingdom

EU Contribution

€ 876 654,90

Project information

Grant agreement ID: 733356

Status

Ongoing project

  • Start date

    1 January 2017

  • End date

    31 December 2021

Funded under:

H2020-EU.3.1.6.

  • Overall budget:

    € 5 902 038,75

  • EU contribution

    € 5 902 038,75

Coordinated by:

UNIVERSITEIT ANTWERPEN

Belgium